Saladaga, Bienvenida L.

HRN: 01-30-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/20/2024
11/27/2024
IV
500mg
Q8
T/C Amoebiasis
Waiting Final Action 
11/20/2024
CIPROFLOXACIN 500MG (TAB)
11/20/2024
11/27/2024
PO
500mg
BID
Intra-abdominal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: